| 000 | 01877 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515162125.0 | ||
| 264 | 0 | _c20091009 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1432-1459 | ||
| 024 | 7 |
_a10.1007/s00415-009-5072-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCavallo, Roberto | |
| 245 | 0 | 0 |
_aRituximab in cryoglobulinemic peripheral neuropathy. _h[electronic resource] |
| 260 |
_bJournal of neurology _cJul 2009 |
||
| 300 |
_a1076-82 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAction Potentials _xdrug effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 |
_aComplement System Proteins _xanalysis |
| 650 | 0 | 4 |
_aCryoglobulinemia _xcomplications |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeural Conduction _xdrug effects |
| 650 | 0 | 4 |
_aPeripheral Nerves _xdrug effects |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
| 650 | 0 | 4 |
_aRheumatoid Factor _xanalysis |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aRoccatello, Dario | |
| 700 | 1 | _aMenegatti, Elisa | |
| 700 | 1 | _aNaretto, Carla | |
| 700 | 1 | _aNapoli, Franca | |
| 700 | 1 | _aBaldovino, Simone | |
| 773 | 0 |
_tJournal of neurology _gvol. 256 _gno. 7 _gp. 1076-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00415-009-5072-z _zAvailable from publisher's website |
| 999 |
_c18703692 _d18703692 |
||